3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
19
Lung Neoplasms
15
Multiple Myeloma
13
Leukemia, Myeloid, Acute
12
Glioma
10
Wilms Tumor
9
Lymphoma, Non-Hodgkin
9
Breast Neoplasms
9
Sarcoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Osteosarcoma
8
Neuroblastoma
8
Neoplasm Metastasis
8
Myelodysplastic Syndromes
8
Colorectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
8
Rhabdoid Tumor
7
Hepatoblastoma
7
Rhabdomyosarcoma
6
Ovarian Neoplasms
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Lymphoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Sarcoma, Ewing
5
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Leukemia, Myelomonocytic, Chronic
5
Interventions
pembrolizumab
3
durvalumab
3
Paclitaxel
3
Doxorubicin
3
Standard of Care
2
Nivolumab
2
Ipilimumab
2
Ifosfamide
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
tremelimumab
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
spartalizumab
1
sintilimab
1
selinexor
1
sarilumab
1
regorafenib
1
pexidartinib
1
pertuzumab
1
peginterferon alfa-2a
1
pazopanib
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hemangiosarcoma
×
X-Rays
×
1 year
×
Clear all
No trials found.